Khan, I., Morris, S., Hackshaw, A., & Lee, S. (2015). Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy. BMJ Open.
Styl cytowania ChicagoKhan, Iftekhar, Stephen Morris, Allan Hackshaw, i Siow-Ming Lee. "Cost-effectiveness of First-line Erlotinib in Patients With Advanced Non-small-cell Lung Cancer Unsuitable for Chemotherapy." BMJ Open 2015.
Styl cytowania MLAKhan, Iftekhar, Stephen Morris, Allan Hackshaw, i Siow-Ming Lee. "Cost-effectiveness of First-line Erlotinib in Patients With Advanced Non-small-cell Lung Cancer Unsuitable for Chemotherapy." BMJ Open 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..